ImmunityBio (IBRX) FCF Margin (2014 - 2026)
ImmunityBio (IBRX) reported FCF Margin of 174.58% for Q1 2026, up 34552.0% year-over-year from N/an in Q1 2025, and up 6.23% on a QoQ basis from 186.19% in Q4 2025.
ImmunityBio (IBRX) has 13 years of FCF Margin data on file, last reported at 174.58% in Q1 2026.
- Quarterly FCF Margin rose 34552.0% year-over-year to 174.58% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 212.84% (up 96869.0% YoY) and the FY2025 annual result came in at 272.56%, up 238078.0% from the prior year.
- FCF Margin rose to 174.58% in Q1 2026 per IBRX's latest filing, from 186.19% in the prior quarter.
- Across five years, FCF Margin topped out at 174.58% in Q1 2026 and bottomed at 542792.86% in Q1 2022.
- The 5-year median for FCF Margin is 28706.39% (2023), against an average of 101746.61%.
- The widest annual swing landed in 2022, when FCF Margin slumped 49622020 bps; it then jumped 51408647 bps in 2023.
- Tracing IBRX's FCF Margin over 5 years: stood at 124590.41% in 2022, then gained by 29 bps to 88651.8% in 2023, then jumped by 99 bps to 1064.18% in 2024, then surged by 83 bps to 186.19% in 2025, then advanced by 6 bps to 174.58% in 2026.
- Per Business Quant, the three latest IBRX FCF Margin figures stand at 174.58% (Q1 2026), 186.19% (Q4 2025), and 219.88% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -3.98% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 43.35% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.53% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 4.17% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -174.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -174.58% |
| Dec 31, 2025 | -186.19% |
| Sep 30, 2025 | -219.88% |
| Jun 30, 2025 | -306.90% |
| Mar 31, 2025 | -520.10% |
| Dec 31, 2024 | -1,064.18% |
| Sep 30, 2024 | -1,663.20% |
| Jun 30, 2024 | -9,653.39% |
| Mar 31, 2024 | -270,607.50% |
| Dec 31, 2023 | -88,651.80% |
| Sep 30, 2023 | -119,560.98% |
| Jun 30, 2023 | -177,395.12% |
| Mar 31, 2023 | -28,706.39% |
| Dec 31, 2022 | -124,590.41% |
| Sep 30, 2022 | -67,470.34% |
| Jun 30, 2022 | -296,128.57% |
| Mar 31, 2022 | -542,792.86% |
| Dec 31, 2021 | -15,418.72% |
| Sep 30, 2021 | -132,619.70% |
| Jun 30, 2021 | -21,733.04% |
| Mar 31, 2021 | -46,572.66% |
| Dec 31, 2020 | -270,976.19% |
| Sep 30, 2020 | -24,497.35% |
| Jun 30, 2020 | -11,014.45% |
| Mar 31, 2020 | -19,075.15% |
| Dec 31, 2019 | -1,182,411.11% |
| Sep 30, 2019 | -156,383.33% |
| Jun 30, 2019 | -94,729.41% |
| Mar 31, 2019 | -302,180.00% |
| Dec 31, 2018 | -109,142.86% |
| Sep 30, 2018 | -68,496.77% |
| Jun 30, 2018 | -468,950.00% |
| Mar 31, 2018 | -408,260.00% |
| Dec 31, 2017 | 2,016.67% |
| Sep 30, 2017 | -260,625.00% |
| Jun 30, 2017 | -165,042.86% |
| Mar 31, 2017 | -132,418.18% |
| Dec 31, 2016 | -86,507.14% |
| Sep 30, 2016 | -114,683.33% |
| Jun 30, 2016 | -77,975.00% |
| Mar 31, 2016 | -165,383.33% |
| Dec 31, 2015 | -79,326.67% |
| Sep 30, 2015 | -53,330.00% |
| Jun 30, 2015 | -3,191.21% |
| Mar 31, 2015 | -6,175.00% |
| Dec 31, 2014 | -2,664.29% |
| Sep 30, 2014 | -702.26% |
| Jun 30, 2014 | -1,655.65% |
| Mar 31, 2014 | -13.29% |